• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

achaogen

  1. Achaogen ZEMDRI® (plazomicin) Which Pharma

    Which Pharma will get their hands on this. Zemdri now FDA approved and exclusivity at least to 2031 or 2032 and EMA approval ahead Roche. ...Pfizer. ...Sanofi. ... Merck. ... GSK (GlaxoSmithKline) ...AstraZeneca. ...Bayer...Johnson & Johnson. who will outbid who